SKYE Skye Bioscience, Inc.

NASDAQ
$1.77

Skye Bioscience, Inc. (SKYE) SEC Filings

Everything SKYE has filed with the SEC, newest first. An 8-K shows what it was about where we have classified it — an earnings release and a change of chief executive are both 8-Ks, and the form number alone doesn't separate them.

30 filings
Date Form Filing
4
4
8-K Agreement Terminated · Executive Change · Material Agreement · Other · Other Event
8-K Capital Raise · Dilution · Material Agreement
4
4
8-K/A Other
SCHEDULE 13D/A
8-K Delisting
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4

Filings are sourced from EDGAR and open on the SEC's own site. Classification of 8-K events is ours and is not part of the filing.